摘要:
The invention concerns the use of the salts of the L-(-)-enantiomer of (endo, syn)-(-)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(methylethyl)-8-azoniabicyclo[3.2.1] octane as active substances for medicaments administered by inhalation for treatment of the respiratory tract. These salts are suitable for such treatment owing to their unexpectedly intense and prolonged effect.
摘要:
De nouveaux composés répondant à la formule (I): AO-CO-Z, dans laquelle A et Z ont la signification donnée dans la description, peuvent être préparés selon des méthodes classiques; ils sont utiles comme substances actives dans des médicaments.
摘要:
The present invention relates to novel pharmaceutical compositions based on PDE IV inhibitors and salts of a new anticholinergic, processes for preparing them and their use in the treatment of respiratory complaints.
摘要:
The present invention relates to novel pharmaceutical compositions based on steroids and salts of a new anticholinergic, processes for preparing them and their use in the treatment of respiratory complaints.
摘要:
The present invention relates to novel pharmaceutical compositions based on beta2 agonists and salts of a new anticholinergic, processes for preparing them and their use in the treatment of respiratory complaints, wherein the anticholinergic agent has the formula (I).
摘要:
The invention concerns the use of the salts of the L-(-)-enantiomer of (endo, syn)-(-)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(methylethyl)-8-azoniabicyclo[3.2.1] octane as active substances for medicaments administered by inhalation for treatment of the respiratory tract. These salts are suitable for such treatment owing to their unexpectedly intense and prolonged effect.